Street Research

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Recommendations
Wacker Chemie price target raised to EUR 205 from EUR 190 at UBS » 15:59
05/20/22
05/20
15:59
05/20/22
15:59
WKCMF

Wacker Chemie

$183.30 /

+ (+0.00%)

UBS analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WKCMF Wacker Chemie
$183.30 /

+ (+0.00%)

05/05/22 Morgan Stanley
Wacker Chemie price target raised to EUR 157 from EUR 145 at Morgan Stanley
04/29/22 Societe Generale
Wacker Chemie downgraded to Sell from Hold at Societe Generale
04/12/22 Barclays
Wacker Chemie price target raised to EUR 197 from EUR 177 at Barclays
04/08/22 Credit Suisse
Wacker Chemie price target raised to EUR 184 from EUR 168 at Credit Suisse
06/07/22
2022 European Materials Conference
Recommendations
RWE AG price target raised to EUR 47.50 from EUR 39 at UBS » 15:58
05/20/22
05/20
15:58
05/20/22
15:58
RWEOY

RWE AG

$45.35 /

+1.03 (+2.32%)

UBS analyst Sam Arie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RWEOY RWE AG
$45.35 /

+1.03 (+2.32%)

05/19/22 Deutsche Bank
RWE AG price target raised to EUR 52 from EUR 48 at Deutsche Bank
05/04/22 Morgan Stanley
RWE AG price target raised to EUR 50 from EUR 45 at Morgan Stanley
04/05/22 Citi
RWE AG price target raised to EUR 45 at Citi
03/31/22 JPMorgan
RWE AG price target lowered to EUR 60 from EUR 64 at JPMorgan
Recommendations
Genmab price target lowered to DKK 2,600 from DKK 2,880 at UBS » 15:58
05/20/22
05/20
15:58
05/20/22
15:58
GMAB

Genmab

$31.06 /

+0.63 (+2.07%)

UBS analyst Laura…

UBS analyst Laura Sutcliffe lowered the firm's price target on Genmab to DKK 2,600 from DKK 2,880 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
GMAB Genmab
$31.06 /

+0.63 (+2.07%)

04/19/22
Genmab announces Q1 net sales of DARZALEX $1.86B
04/13/22
Genmab and AbbVie report Phase 1/2 results of epcoritamab in LBCL
04/07/22
Genmab announces resolution to arbitration with Janssen on Daratumumab
03/08/22
Genmab announces FDA grants orphan-drug designation to epcoritamab
GMAB Genmab
$31.06 /

+0.63 (+2.07%)

05/13/22 JPMorgan
Genmab price target lowered to DKK 2,700 from DKK 3,100 at JPMorgan
05/13/22 Berenberg
Genmab upgraded to Hold from Sell at Berenberg
05/13/22 Bryan Garnier
Genmab upgraded to Neutral from Sell at Bryan Garnier
05/02/22 Cowen
Genmab initiated with a Market Perform at Cowen
GMAB Genmab
$31.06 /

+0.63 (+2.07%)

05/11/22
Genmab narrows 2022 revenue view DKK 11B - DKK 12B from DKK 10.8B - DKK 12B
05/11/22
Genmab reports Q1 revenue DKK 2.1B vs. DKK 1.58B last year
GMAB Genmab
$31.06 /

+0.63 (+2.07%)

05/02/22
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
06/03/22
2022 ASCO Annual Meeting
Recommendations
Siegfried price target lowered to CHF 840 from CHF 970 at RBC Capital » 15:38
05/20/22
05/20
15:38
05/20/22
15:38
SGFEF

Siegfried

$730.00 /

+ (+0.00%)

RBC Capital analyst…

RBC Capital analyst Charles Weston lowered the firm's price target on Siegfried to CHF 840 from CHF 970 and keeps an Outperform rating on the shares.

ShowHide Related Items >><<
SGFEF Siegfried
$730.00 /

+ (+0.00%)

10/19/21 Exane BNP Paribas
Siegfried initiated with an Outperform at Exane BNP Paribas
Recommendations
Julius Baer price target lowered to CHF 60 from CHF 65 at RBC Capital » 15:37
05/20/22
05/20
15:37
05/20/22
15:37
JBAXY

Julius Baer

$9.42 /

-0.43 (-4.37%)

RBC Capital analyst Anke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JBAXY Julius Baer
$9.42 /

-0.43 (-4.37%)

15:14 Today Credit Suisse
Julius Baer price target lowered to CHF 65 from CHF 68 at Credit Suisse
05/19/22 JPMorgan
Julius Baer price target raised to CHF 65 from CHF 63 at JPMorgan
05/13/22 Morgan Stanley
Julius Baer price target lowered to CHF 63 from CHF 74 at Morgan Stanley
04/07/22 Societe Generale
Julius Baer upgraded to Buy from Hold at Societe Generale
Recommendations
Rockwool price target lowered to DKK 2,485 from DKK 2,570 at Morgan Stanley » 15:34
05/20/22
05/20
15:34
05/20/22
15:34
RKWAF

Rockwool

$378.59 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RKWAF Rockwool
$378.59 /

+ (+0.00%)

14:38 Today JPMorgan
Rockwool price target lowered to DKK 1,860 from DKK 1,970 at JPMorgan
04:53 Today Societe Generale
Rockwool upgraded to Hold from Sell at Societe Generale
04:49 Today Exane BNP Paribas
Rockwool upgraded to Neutral from Underperform at Exane BNP Paribas
Recommendations
MorphoSys price target lowered to EUR 37 from EUR 40 at Morgan Stanley » 15:34
05/20/22
05/20
15:34
05/20/22
15:34
MOR

MorphoSys

$5.18 /

+0.12 (+2.37%)

Morgan Stanley analyst…

Morgan Stanley analyst James Quigley lowered the firm's price target on MorphoSys to EUR 37 from EUR 40 and keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
MOR MorphoSys
$5.18 /

+0.12 (+2.37%)

05/12/22
MorphoSys to present new data on Pelabresib and Monjuvi at EHA and ASCO
03/22/22
MorphoSys, Incyte say Swissmedic temporarily clears Minjuvi-Lenalidomi combo
03/10/22
MorphoSys discontinues U.S. discovery activities, takes EUR 231M charge
01/25/22
MorphoSys CEO believes M&A will stay firmly on biopharma agenda in 2022
MOR MorphoSys
$5.18 /

+0.12 (+2.37%)

04/04/22 Morgan Stanley
MorphoSys price target lowered to EUR 40 from EUR 50 at Morgan Stanley
03/24/22 Berenberg
MorphoSys initiated with a Buy at Berenberg
03/22/22 Deutsche Bank
MorphoSys price target lowered to EUR 30 from EUR 46 at Deutsche Bank
03/22/22 Citi
MorphoSys price target lowered to EUR 31 at Citi
MOR MorphoSys
$5.18 /

+0.12 (+2.37%)

03/16/22
MorphoSys reports Q4 net loss EUR (381M) vs. loss EUR (16.5M) y/y
MOR MorphoSys
$5.18 /

+0.12 (+2.37%)

01/25/22
Meet MorphoSys: Fly exclusive interview with CEO Jean-Paul Kress
08/04/22
MorphoSys - MOR
Recommendations
DCC plc price target lowered to 7,855 GBp from 8,160 GBp at Morgan Stanley » 15:30
05/20/22
05/20
15:30
05/20/22
15:30
DCCPF

DCC plc

$74.93 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Annelies Vermeulen lowered the firm's price target on DCC plc to 7,855 GBp from 8,160 GBp and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
DCCPF DCC plc
$74.93 /

+ (+0.00%)

05/18/22 JPMorgan
DCC plc price target raised to 7,500 GBp from 7,000 GBp at JPMorgan
12/17/21 Credit Suisse
DCC plc price target raised to 7,250 GBp from 7,000 GBp at Credit Suisse
12/16/21 JPMorgan
DCC plc price target raised to 8,349 GBp from 7,640 GBp at JPMorgan
12/15/21 Barclays
DCC plc downgraded to Underweight from Equal Weight at Barclays
Recommendations
QinetiQ price target raised to 361 GBp from 331 GBp at Morgan Stanley » 15:29
05/20/22
05/20
15:29
05/20/22
15:29
QNTQY

QinetiQ

$17.90 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QNTQY QinetiQ
$17.90 /

+ (+0.00%)

14:34 Today JPMorgan
QinetiQ price target raised to 355 GBp from 350 GBp at JPMorgan
04/28/22 JPMorgan
QinetiQ price target raised to 350 GBp from 345 GBp at JPMorgan
04/22/22 Berenberg
QinetiQ price target raised to 400 GBp from 335 GBp at Berenberg
03/18/22 JPMorgan
QinetiQ price target raised to 345 GBp from 320 GBp at JPMorgan
Recommendations
Future plc price target lowered to 3,253 GBp from 4,512 GBp at Deutsche Bank » 15:18
05/20/22
05/20
15:18
05/20/22
15:18
FRNWF

Future plc

$23.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRNWF Future plc
$23.00 /

+ (+0.00%)

03/24/22
Future plc acquires WhatCulture, Waive, terms not disclosed
03/16/22
Marie Clare launches shopping experience Marie Clare Edit
11/29/21
Taboola, Future plc announce multi-year renewal of partnership
FRNWF Future plc
$23.00 /

+ (+0.00%)

05/19/22 Berenberg
Future plc price target lowered to 3,600 GBp from 5,225 GBp at Berenberg
04/25/22 Barclays
Future plc price target lowered to 3,300 GBp from 3,900 GBp at Barclays
12/01/21 Berenberg
Future plc price target raised to 5,225 GBp from 4,890 GBp at Berenberg
12/01/21 Deutsche Bank
Future plc price target raised to 4,512 GBp from 4,138 GBp at Deutsche Bank
FRNWF Future plc
$23.00 /

+ (+0.00%)

05/18/22
Future plc reports half-year revenue $541M

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.